
==== Front
Nat Commun
Nat Commun
Nature Communications
2041-1723
Nature Publishing Group UK London

39223144
52134
10.1038/s41467-024-52134-7
Article
Divergent syntheses of complex Veratrum alkaloids
Guo Yinliang 1
Fang Runting 2
Jiao Yang 1
Liu Jiaqi 1
Lu Jia-Tian 1
http://orcid.org/0000-0003-2156-3198
Luo Tuoping tuopingluo@pku.edu.cn

123
1 grid.11135.37 0000 0001 2256 9319 Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education, Beijing National Laboratory for Molecular Science, College of Chemistry and Molecular Engineering, Peking University, Beijing, China
2 https://ror.org/02v51f717 grid.11135.37 0000 0001 2256 9319 Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
3 https://ror.org/00sdcjz77 grid.510951.9 0000 0004 7775 6738 Institute of Molecular Physiology, Shenzhen Bay Laboratory, Shenzhen, Guangdong China
2 9 2024
2 9 2024
2024
15 763928 6 2024
27 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The Veratrum alkaloids are a class of highly intricate natural products renowned for their complex structural and stereochemical characteristics, which underlie a diverse array of pharmacological activities ranging from anti-hypertensive properties to antimicrobial effects. These properties have generated substantial interest among both synthetic chemists and biologists. While numerous advancements have been made in the synthesis of jervanine and veratramine subtypes over the past 50 years, the total synthesis of highly oxidized cevanine subtypes has remained relatively scarce. Building on the efficiency of our previously developed strategy for constructing the hexacyclic carbon skeleton of the Veratrum alkaloid family via a stereoselective intramolecular Diels-Alder reaction and radical cyclization, here we show the development of a unified synthetic approach to access highly oxidized Veratrum alkaloids. This includes the total synthesis of (–)-zygadenine, (–)-germine, (–)-protoverine and the alkamine of veramadine A, by capitalizing on a meticulously designed sequence of redox manipulations and a late-stage neighboring-group participation strategy.

The Veratrum alkaloids are a class of highly intricate natural products renowned for their complex structural and stereochemical characteristics. Herein, the authors report the divergent synthesis of zygadenine, germine, protoverine and the alkamine of veramadine A, capitalizing on a late-stage neighboring group participation.

Subject terms

Natural product synthesis
Natural product synthesis
Diversity-oriented synthesis
https://doi.org/10.13039/501100001809 National Natural Science Foundation of China (National Science Foundation of China) 22171011, 21977002, 21822101 Luo Tuoping https://doi.org/10.13039/501100011620 Center for Life Sciences (CLS) Beijing National Laboratory for Molecular Sciences Shenzhen Bay Laboratoryissue-copyright-statement© Springer Nature Limited 2024
==== Body
pmcIntroduction

The Veratrum alkaloids constitute a family of steroidal alkaloids characterized by a unique C-nor-D-homo steroid skeleton (Fig. 1). These alkaloids are widely distributed across various species of Veratrum and Zigadenus, comprising three subtypes (jervanine, veratramine, cevanine) and encompassing over 200 compounds1–3. Notably, several members of this alkaloid family are recognized for their distinctive biological activities or toxic effects. For instance, cyclopamine and jervine exhibit pronounced teratogenicity by blocking the Hedgehog signaling pathway4–6; zygadenine, found in death camas species, induces poisoning in livestock7,8; germine and protoverine demonstrate antihypertensive properties9,10, and veratridine binds to voltage-gated sodium channels, acting as either an agonist or antagonist in a context- and subtype-dependent manner11–13. The intricate structures and significant biological activities of these compounds have sparked considerable interest within both the synthetic and biological research communities.Fig. 1 Reported syntheses of Veratrum alkaloids.

a Framework of the jervanine subgroup. b Framework of the veratramine subgroup. c Framework of the cevanine subgroup.

Over the past 50 years, continuous synthetic breakthroughs have significantly advanced the synthesis of the jervanine and veratramine subtypes. In 1967, Masamune’s group and Johnson’s group independently achieved the synthesis of jervine and veratramine, respectively14–16. Kutney’s group reported the total synthesis of verarine in 197617, employing a strategy involving the hydrogenation of a pyridine unit to construct the F ring; they subsequently applied the same strategy in the synthesis of verticine18,19. In 2009, Giannis’ group introduced a semisynthetic route to cyclopamine20, while in 2023, both Baran’s group21 and Gao’s group22 separately disclosed the total synthesis of (–)-cyclopamine. Most recently, in 2024, Qin, Liu and coworkers reported divergent and gram-scale syntheses of (–)-veratramine and (–)-cyclopamine from dehydro-epi-androsterone in an efficient manner23. Shifting focus to the cevanine subtype, Rawal’s group achieved the synthesis of (+)-heilonine in 202124, and more recently in 2024. Dai’s group also reported its synthesis25. However, total syntheses of highly oxidized cevanine subtype alkaloids have remained limited. An important contribution in this context was made by Stork’s group26, where they successfully synthesized (±)−4-methylenegermine, which features only one additional methylene group compared to germine.

Zygadenine (1), germine (2) and protoverine (3) are highly oxidized members of the cevanine subgroup and serve as core alkamines for various natural products that exist as esters or polyesters of their hydroxyl groups, including germemine27, neogermitrine28, germitetrine29, and protoveratrines30. Several of these alkaloids were previously used clinically for hypertension management9. However, due to adverse reactions such as neurotoxicity, safer alternatives have since replaced them10. Nevertheless, compounds 1, 2 and 3, distinguished by increasing oxidation levels and multiple hydroxyl groups intricately embedded in the A-E rings, present opportunities for strategic innovation in accessing Veratrum alkaloids. In our prior work, we employed an intramolecular Diels−Alder reaction/radical cyclization strategy to construct the hexacyclic carbon skeleton, followed by a meticulously designed sequence of redox manipulations to complete the total synthesis of (–)-zygadenine (1)31. Herein, we unveil a late-stage neighboring group participation strategy, resulting in a divergent and enantioselective total synthesis of zygadenine (1), germine (2), protoverine (3), and the alkamine of veramadine A (4)30.

Results and discussion

Retrosynthetic design

By analyzing the differences in these target molecules, we envisioned a divergent synthetic strategy and logically traced them back to intermediate 5 (Fig. 2). Starting from compound 8 communicated in our previous publication31, hydrogenation of the Δ6,7-alkene followed by subsequent redox and protection/deprotection manipulations could transform it into zygadenine (1). In comparison, for germine (2), protoverine (3), and the alkamine of veramadine A (4), the installation of the C6 and/or C7 hydroxyl groups must be achieved in a regio- and stereoselective manner, alongside the introduction of the C3 and C4 oxidation states. Tactically, the functionalization of the Δ6,7-alkene could proceed before the C3 reduction, regioselective elimination, dihydroxylation, and subsequent stepwise protections that install the protected hydroxyl groups at C3 and C4 (approach A), and intermediate 6 was hence devised. Alternatively, the protected hydroxyl groups at C3 and C4 could be secured first, followed by the functionalization of the Δ6,7-alkene (via 7, approach B). Either way, the challenges associated with the chemo-, regio-, and stereochemical selectivity of late-stage transformations in a complicated polycyclic skeleton should not be underestimated, and significant experimentation was anticipated to achieve the desired results.Fig. 2 Retrosynthetic analysis of complex Veratrum alkaloids.

The structure of veramadine A was highlighted in light gray background.

Implementation of a late-stage neighboring-group participation to functionalize the Δ6,7-alkene

We commenced by adjusting the oxidation states of C6 and C7 through transformations of the Δ6,7-alkene moiety within the cis-decahydronaphthalene framework of 8. Initially, a direct oxidation strategy was employed (Fig. 3a). However, dihydroxylation of 8 with OsO4 resulted in diol 9 with incorrect stereochemistry at C6 and C7, likely due to significant steric hindrance on the α surface in the AB-ring system. Evaluating Woodward cis-hydroxylation conditions (AgOAc, I2) on 8 revealed a side reaction involving the nucleophilic attack of the C9-OH on the iodonium intermediate32, yielding the undesired product 10.Fig. 3 Evolution of strategies to functionalize the Δ6,7-alkene.

a Attempted dihydroxylation of the Δ6,7-alkene. b Initial exploration of the neighboring-group participation strategy. c Analysis of the successful elimination reaction in 18. d The failed attempt to access the substrate with free C9-OH via a carbonate intermediate. Reagents and conditions: (a) OsO4, pyridine, 0 °C to rt, overnight, 85%. b AgOAc, I2, AcOH, overnight, 70%. c NaBH4, DCM/MeOH=1:4, 0 °C, 30 min, 82%. d NaHMDS, TBSCl, then Bz2O, THF, 0 °C, 1 h, 80%. e IBr, MeCN, buffer (pH = 7), 28 °C, 2 h, 85%. f AIBN, nBu3SnH, benzene, reflux, 1 h then TBAF, THF, rt, 2 h, 81%. g TsCl, pyridine, rt, 5 h, 90%. h NaHMDS, TBSCl, then Boc2O, THF, 0 °C, 1 h, 80%. i IBr, MeCN, buffer (pH = 7), 28 °C, 2 h, 80%.

These initial endeavors sparked the investigation of a neighboring-group participation strategy by leveraging the C9-OH group (Fig. 3b). Reduction of 1131 by NaBH4, which approached the C3 carbonyl group from the convex face, gave 12 in 82% yield as a single isomer. Protection of the C3-OH in 12 using TBS, followed by benzoylation of the C9-OH in a one-pot procedure, provided 13 in 80% yield. Notably, this method (NaHMDS/Bz2O) exhibited remarkable efficiency for the acylation of the C9-OH, representing a rare example of benzoylation on a tertiary hydroxyl group despite the considerable steric hinderance. Treatment of 13 with IBr afforded orthoester 14 in 85% yield. This cascade event proceeded via oxocarbenium intermediate A, which engaged the neighboring oxygen at the C14 position to form the orthoester, leading to the selective deprotection of the C14, C15-benzylidene acetal. With the correct oxidation level and configuration at C7 successfully attained, we employed radical dehalogenation of the C-6 iodide and deprotected the TBS group to yield 15. We then examined the elimination/dihydroxylation strategy for introducing the C4 oxidation state. However, after tosylation of the C3-OH, the elimination did not occur upon treatment with tBuOK, resulting in the recovery of tosylate 16.

This experimental observation prompted a careful assessment of the mechanism underlying the elimination of C3-OTs. The elimination in substrate 18 to form the Δ3,4-alkene could be realized, as communicated in our former publication31. A plausible explanation is that the elimination reaction to form the Δ3,4-alkene requires C3–OTs and C4-β-H to be trans-coplanar, necessitating the A-ring to adopt a twist-boat conformation (B, Fig. 3c). This conformation can occur in substrate 18. However, in substrate 16, the B-ring conformation was locked by the orthoester structure, adding extra conformational constraints in the AB ring system, and making it difficult to achieve the necessary conformation in the A-ring for the trans-elimination. Therefore, we opted to protect the C9–OH with a Boc group, yielding intermediate 20, which was then treated with IBr to afford 21 in 80% yield (Fig. 3d). We then attempted to deprotect the C9–OH to release the conformational constraint in the AB system to ensure the elimination reaction. However, removing the carbonate group via alkaline hydrolysis proved challenging. Instead of obtaining 22 or the corresponding epoxide, we observed the recovery of starting material 21, indicating significant steric hinderance near the carbonate, likely due to the A-ring and the benzylidene acetal on C14,C15-diol.

Total syntheses of (–)-zygadenine, (–)-germine, (–)-protoverine, and the alkamine of veramadine A

Subsequently, the reaction sequence was modified so that the neighboring-group participation reaction occurred after the elimination/dihydroxylation of the C3-C4 position (Fig. 4). Initially, compound 12 underwent the elimination of the C3-OH through tosylation and treatment with tBuOK, leading to the formation of the Δ3,4-alkene product in 20% yield, which was contaminated by Δ2,3-alkene and Δ4,5-alkene byproduct. After screening conditions, we were able to regio-selectively obtain the desired Δ3,4-alkene product (23) in 80% isolated yield by controlling the reaction temperature to –25 °C and adding tBuOK solid slowly in batches. Next, we attempted the regio- and facial-selective dihydroxylation of the Δ3,4-alkene of 23. Under OsO4/pyridine treatment, the desired product 21 was obtained in only 13% yield, along with byproducts from dihydroxylation of the Δ6,7-alkene and both the Δ3,4-alkene and Δ6,7-alkene. After careful optimization, the regioselective product 24 was obtained in 57% yield (80% brsm) by dropwisely adding the OsO4 solution at low temperature. Mono-protection with TBS provided separable regioisomers 25a and 25b in 31% and 51% yields, respectively, with the undesired regioisomer (25a) being recyclable. Intermediate 25b was further converted to 7, the late-stage common intermediate for our total synthesis endeavor, by installing a BOM protecting group on the C3–OH. For the synthesis of (–)-zygadenine (1), the C6‒C7 alkene was hydrogenated, and the C4–OH was deprotected via TBAF treatment in a one-pot fashion, resulting in the intermediate 26, which could be directed towards (–)-1 using identical reaction sequences in our previous publication31.Fig. 4 Formal synthesis of (–)-zygadenine (1) and synthesis of the alkamine of veramadine A (–)-4.

Reagents and conditions: a TsCl, pyridine, 50 °C, 2 h then tBuOK, toluene, DMSO, –78 °C to –25 °C, 30 min, 80%. b OsO4, pyridine, THF, –40 °C, 2 h, 57% (80% brsm). c TBSCl, imidazole, DMAP, DCM, rt, overnight, 82% (68a/68b = 3:5) d BOMCl, DIPEA, TBAI, DCE, 80 °C, 1 h, 97%. e Pd/C, EtOAc, Et3N, H2 (7 MPa), rt, 20 h then TBAF, THF, 70 °C, 5 h, 65%. f NaHMDS, Bz2O, THF, 0 °C, 1 h, 97%. g IBr, MeCN, buffer (pH=7), 28 °C, 2 h, 56%. h NaHMDS, CS2, THF, –78 °C, 10 min then MeI, –78 °C, 30 min, 72%. i AIBN, nBu3SnH, benzene, reflux, 1.5 h then TBAF, THF, reflux, 3 h, quant. j DMP, NaHCO3, DCM, rt, 15 h, 84%. k Pd(OH)2/C, MeOH, H2 (1 atm), rt, 5 h. l Et2SiH2, [Ir(COE)2Cl]2, toluene, reflux, 3 h then MeCN, HF (40% aq.), rt, overnight, 62% (2 steps). brsm, yield based on the recovered starting material; BOMCl, Benzyl chloromethyl ether; DMP, Dess-Martin periodinane.

We then proceeded to diverge from 7 to obtain 2, 3 and 4. The alkamine of veramadine A (4)30, a congener with the same oxidation level as zygadenine (1), was targeted first. A benzoyl group was introduced to the C9-OH to give 27, and subsequent IBr treatment afforded orthoester 28 in 56% yield. Conversion of the C15–OH to the corresponding xanthate 29 was followed by radical defunctionalization to adjust the oxidation levels at C6 and C15, and one-pot TBAF treatment afforded alcohol 30. The C4-OH group was then oxidized to a ketone to give 31 in 84% yield, and global deprotection via palladium-catalyzed hydrogenation released the C9-OH to form the hemiketal (32), serving as protection of the C4-ketone during iridium-catalyzed silane-reduction33. Notably, silylation of the hydroxyl groups occurred during this final transformation; therefore, hydrofluoric acid treatment was performed in the same reaction flask after the reduction, leading to the isolation of the alkamine of veramadine A (4) in 62% yield over two steps.

To access germine (2), radical dehalogenation of the iodide in 28 was followed by protecting the C15-OH group with a BOM group, and TBAF treatment was performed in a one-pot fashion to yield 33 (Fig. 5). This was followed by DMP oxidation of the C4-OH group to deliver ketone 34. Sequential global deprotection and final amide reduction then afforded (–)-germine (2) in 45% yield over two steps. The elaboration of 28 to protoverine (3) commenced with the transformation of C6-I to a TEMPO group, resulting in 35 using Boger’s protocol34. Subsequent peroxy acid oxidation produced the C6 ketone 36, which was then reduced by NaBH4 to introduce the β-C6-OH group, yielding 37. Intermediate 37 underwent BOM protection of both the C6 and C15 hydroxyl groups, followed by desilylation of the TBS-protected C4–OH group, leading to the formation of 38. A subsequent DMP oxidation step resulted in ketone 39 in 78% yield. The final steps involved the same global deprotection and amide reduction sequence as previously utilized for 4, culminating in the total synthesis of (–)-protoverine (3). The NMR spectra of the synthesized samples of 2 were consistent with those reported in the literature (Supplementary Table 2)30,35, while the structures of 2 and 4 were unambiguously verified by X-ray diffraction analysis; the stereochemistry of 3 was determined through 2D NMR experiments due to the unavailability of NMR spectra data of the isolated sample.Fig. 5 Syntheses of (–)-germine (2) and (–)-protoverine (3).

Reagents and conditions: a nBu3SnH, AIBN, benzene, reflux, 1.5 h then BOMCl, TBAI, DIPEA, DCE, 80 °C, 2 h then TBAF, THF, reflux, 3 h, 89%. b DMP, NaHCO3, DCM, 30 °C, 13 h, 72%. c Pd(OH)2/C, MeOH, H2 (1 atm), rt, 5 h. d Et2SiH2, [Ir(COE)2Cl]2, toluene, reflux, 3 h then MeCN, HF (40% aq.), rt, overnight, 45% (2 steps). e TEMPO, nBu3SnH, toluene, reflux, 3 h, 87%. f UHP, Na2CO3, TFAA, DCM, 0 °C, 6 h, 81%. g NaBH4, MeOH, 0 °C, 30 min, 85%. h BOMCl, TBAI, DIPEA, DCE, 80 °C, 2 h, then TBAF, THF, reflux, 3 h, 81%. i DMP, NaHCO3, DCM, 30 °C, 14 h, 78%. j Pd(OH)2/C, MeOH, H2 (1 atm), rt, 5 h. k Et2SiH2, [Ir(COE)2Cl]2, toluene, reflux, 3 h then MeCN, HF (40% aq.), rt, overnight, 53% (2 steps). UHP, urea hydrogen peroxide; TFAA, trifluoroacetic anhydride.

In summary, we have developed a successful divergent approach for the syntheses of (–)-zygadenine (1), (–)-germine (2), (–)-protoverine (3) and the alkamine of veramadine A (4). The primary challenge lay in achieving chemo-, regio- and stereoselectivity during the late-stage transformations, especially redox sequence, within this complex and highly oxidized framework. Ultimately, the functionalization of the C6-C7 alkene using neighboring-group participation (C9-OBz) after the introduction of the protected C4-OH proved to be an essential tactic. This synthetic strategy not only provides a pathway to access other important members of the Veratrum family of alkaloids but also offers opportunities for further exploration of their pharmacological properties.

Methods

Unless otherwise mentioned, all reactions were carried out under a nitrogen atmosphere with dry solvents under anhydrous conditions. All the chemicals were purchased commercially, and used without further purification. Anhydrous THF was distilled from sodium-benzophenone, toluene was distilled from sodium, dichloroethane and dichloromethane were distilled from calcium hydride according to Purification of Laboratory Chemicals (Peerrin, D. D.; Armarego, W. L. and Perrins, D. R., Pergamon Press: Oxford, 1980). Reactions were monitored by thin layer chromatography (TLC) carried out on 0.25 mm E. Merck silica plates (60F-254), using UV light as the visualizing agent and an ethanolic solution of ammonium molybdate and heat, or KMnO4 and heat as developing agents. If not specially mentioned, flash column chromatography uses silica gel (200–300 mesh) supplied by Tsingtao Haiyang Chemicals (China). NMR spectra were recorded on Brüker Advance 400 (1H 400 MHz, 13C 100 MHz), Brüker Advance 500 (1H 500 MHz, 13C 125 MHz), Brüker Advance 600 (1H 600 MHz, 13C 150 MHz) or Brüker Advance 800 (1H 800 MHz, 13C 200 MHz). TMS was used as internal standard for 1H NMR (0.00 ppm), and solvent signal was used as reference for 1H NMR (CDCl3, 7.26 ppm, CD2Cl2, 5.32 ppm, CD3OD, 3.31 ppm, CD3COCD3, 2.05 ppm, C6D6, 7.16 ppm), 13C NMR (CDCl3, 77.16 ppm, CD2Cl2, 54.0 ppm, CD3OD, 49.00 ppm, CD3COCD3, 206.26, 29.84 ppm, C6D6, 128.06 ppm). The following abbreviations were used to explain the multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. Mass spectrometric data were obtained using Brüker Apex IV FTMS using ESI (electrospray ionization) and Waters GCT (GC-MS) using EI (electron impact ionization). Infrared spectra were recorded on a Thermo Nicolet iS5 spectrometer. Optical rotations were measured on an InsMark IP-digi300 digital polarimeter with a LED light source at ambient temperature and are reported as follows: [α]λ (c g/100 mL).

Supplementary information

Supplementary Information

Peer Review File

Supplementary information

The online version contains supplementary material available at 10.1038/s41467-024-52134-7.

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grants 22171011, 21977002, and 21822101), College of Chemistry and Molecular Engineering, Peking University, Beijing National Laboratory for Molecular Sciences, Peking-Tsinghua Center for Life Sciences, and Shenzhen Bay Laboratory. The measurements of NMR, mass spectrometry, and XRD were performed at the Analytical Instrumentation Center of Peking University. The NMR experiments of 800 MHz were performed at the Beijing NMR Center and the NMR facility of the National Center for Protein Sciences at Peking University. We acknowledge the assistance and support from PKUAIC and support from the High-Performance Computing Platform of Peking University.

Author contributions

The overall design of this project was conceptualized by Y.G. and T.L. with input from R.F., Y.J., and J.L.; Y.G., R.F., Y.J., J.L., and J.-T.L. conducted the chemical experiments. The manuscript was written and edited jointly by Y.G. and T. L. with feedback from other authors.

Peer review

Peer review information

Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available.

Data availability

The additional data generated in this study are provided in the Supplementary Information. The X-ray crystallographic for the structures reported in this study have been deposited at the Cambridge Crystallographic Data Center (CCDC), under deposition numbers CCDC 2278629 (25b), CCDC 2278631 (4) and CCDC 2278630 (2). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/. (also see ‘X-Ray Crystallographic Data’ in Supplementary Information). All data are available from the corresponding author upon request.

Competing interests

The other authors declare no competing interests.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

These authors contributed equally: Yinliang Guo, Runting Fang, Yang Jiao.
==== Refs
References

1. Greenhill, J. V. & Grayshan, P. The Cevane Group of Veratrum Alkaloids; Academic Press: 41, 177−252 (1992).
2. Heretsch, P. & Giannis, A. The Veratrum and Solanum Alkaloids; Academic Press: 74, 201−232 (2015).
3. Dirks ML Seale JT Collins JM McDougal OM Review: Veratrum californicum alkaloids Molecules 2021 26 5934 5953 10.3390/molecules26195934 34641477
Dirks, M. L., Seale, J. T., Collins, J. M. & McDougal, O. M. Review: Veratrum californicum alkaloids. Molecules 26, 5934–5953 (2021).34641477 10.3390/molecules26195934
4. Incardona JP Gaffield W Kapur RP Roelink H The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction Development 1998 125 3553 3562 10.1242/dev.125.18.3553 9716521
Incardona, J. P., Gaffield, W., Kapur, R. P. & Roelink, H. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125, 3553–3562 (1998).9716521 10.1242/dev.125.18.3553
5. Chen JK Taipale J Cooper MK Beachy PA Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened Genes Dev. 2002 16 2743 2748 10.1101/gad.1025302 12414725
Chen, J. K., Taipale, J., Cooper, M. K. & Beachy, P. A. Inhibition of hedgehog signaling by direct binding of cyclopamine to smoothened. Genes Dev. 16, 2743–2748 (2002).12414725 10.1101/gad.1025302
6. Chen J I Only Have eye for ewe: the discovery of cyclopamine and development of hedgehog pathway-targeting drugs Nat. Prod. Rep. 2016 33 595 601 10.1039/C5NP00153F 26787175
Chen, J. I Only Have eye for ewe: the discovery of cyclopamine and development of hedgehog pathway-targeting drugs. Nat. Prod. Rep. 33, 595–601 (2016).26787175 10.1039/C5NP00153F
7. Budzikiewicz H Zum massenspektroskopischen fragmentierungsverhalten von steroidalalkaloiden Tetrahedron 1964 20 2267 2278 10.1016/S0040-4020(01)97614-8
Budzikiewicz, H. Zum massenspektroskopischen fragmentierungsverhalten von steroidalalkaloiden. Tetrahedron 20, 2267–2278 (1964).10.1016/S0040-4020(01)97614-8
8. Gilbertson TJ Zygacine and zygadenine: the major alkaloids from Zygadenus gramineus Phytochemistry 1973 12 2079 2080 10.1016/S0031-9422(00)91555-3
Gilbertson, T. J. Zygacine and zygadenine: the major alkaloids from Zygadenus gramineus. Phytochemistry 12, 2079–2080 (1973).10.1016/S0031-9422(00)91555-3
9. Meilman E The management of hypertensive cardiovascular disease Circulation 1956 13 596 607 10.1161/01.CIR.13.4.596 13356417
Meilman, E. The management of hypertensive cardiovascular disease. Circulation 13, 596–607 (1956).13356417 10.1161/01.CIR.13.4.596
10. Zhao Y Research development towards the pharmacology and toxicology of Veratrum alkaloids Tradit. Chin. Drug Res. Clin. Pharmacol. 2008 19 240 242
Zhao, Y. et al. Research development towards the pharmacology and toxicology of Veratrum alkaloids. Tradit. Chin. Drug Res. Clin. Pharmacol. 19, 240–242 (2008).
11. Zhang X-y Bi R-y Zhang P Gan Y-h Vetradine modifies the gating of human voltage-gated sodium channel Nav1.7 Acta Pharmacol. Sin. 2018 39 1716 1724 10.1038/s41401-018-0065-z 29950616
Zhang, X.-y, Bi, R.-y, Zhang, P. & Gan, Y.-h Vetradine modifies the gating of human voltage-gated sodium channel Nav1.7. Acta Pharmacol. Sin. 39, 1716–1724 (2018).29950616 10.1038/s41401-018-0065-z
12. Craig RA Garrison CE Nguyen PT Yarov-Yarovoy V Du Bois J Veratridine: a Janus-faced modulator of voltage-gated sodium ion channels Acs. Chem. Neurosci. 2020 11 418 426 10.1021/acschemneuro.9b00621 31951114
Craig, R. A., Garrison, C. E., Nguyen, P. T., Yarov-Yarovoy, V. & Du Bois, J. Veratridine: a Janus-faced modulator of voltage-gated sodium ion channels. Acs. Chem. Neurosci. 11, 418–426 (2020).31951114 10.1021/acschemneuro.9b00621
13. Gulsevein A Veratridine can bind to a site at the mouth of the channel pore at human cardiac sodium channel NaV1.5 Int. J. Mol. Sci. 2022 23 2225 10.3390/ijms23042225 35216338
Gulsevein, A. et al. Veratridine can bind to a site at the mouth of the channel pore at human cardiac sodium channel NaV1.5. Int. J. Mol. Sci. 23, 2225 (2022).35216338 10.3390/ijms23042225
14. Masamune T Takasugi M Murai A Kobayashi K C-Nor-D-homo steroids and related alkaloids. IX. Synthesis of jervine and related alkaloids J. Am. Chem. Soc. 1967 89 4521 4523 10.1021/ja00993a048
Masamune, T., Takasugi, M., Murai, A. & Kobayashi, K. C-Nor-D-homo steroids and related alkaloids. IX. Synthesis of jervine and related alkaloids. J. Am. Chem. Soc. 89, 4521–4523 (1967).10.1021/ja00993a048
15. Johnson WS DeJongh HAP Coverdale CE Scott JW Burckhardt U Synthesis of veratramine J. Am. Chem. Soc. 1967 89 4523 4524 10.1021/ja00993a049
Johnson, W. S., DeJongh, H. A. P., Coverdale, C. E., Scott, J. W. & Burckhardt, U. Synthesis of veratramine. J. Am. Chem. Soc. 89, 4523–4524 (1967).10.1021/ja00993a049
16. Johnson WS Cox JM Graham DW Whitlock HW The total synthesis of 17-acetyl-5α-etiojerva-12,14,16-trien-3β-ol J. Am. Chem. Soc. 1967 89 4524 4526 10.1021/ja00993a050
Johnson, W. S., Cox, J. M., Graham, D. W. & Whitlock, H. W. The total synthesis of 17-acetyl-5α-etiojerva-12,14,16-trien-3β-ol. J. Am. Chem. Soc. 89, 4524–4526 (1967).10.1021/ja00993a050
17. Kutney JP Total synthesis of steroidal derivatives. V. The total synthesis of Veratrum alkaloids. 1. verarine J. Am. Chem. Soc. 1968 90 5332 5334 10.1021/ja01021a083 5670800
Kutney, J. P. et al. Total synthesis of steroidal derivatives. V. The total synthesis of Veratrum alkaloids. 1. verarine. J. Am. Chem. Soc. 90, 5332–5334 (1968).5670800 10.1021/ja01021a083
18. Kutney JP Synthetic studies in the Veratrum alkaloid series. The total synthesis of C18-functionalized C-nor-D-homo steroid derivatives-valuable intermediates in the total synthesis of Veratrum alkaloids J. Am. Chem. Soc. 1977 99 963 964 10.1021/ja00445a059 833389
Kutney, J. P. et al. Synthetic studies in the Veratrum alkaloid series. The total synthesis of C18-functionalized C-nor-D-homo steroid derivatives-valuable intermediates in the total synthesis of Veratrum alkaloids. J. Am. Chem. Soc. 99, 963–964 (1977).833389 10.1021/ja00445a059
19. Kutney JP Synthetic studies in the Veratrum alkaloid series. The total synthesis of verticine J. Am. Chem. Soc. 1977 99 964 966 10.1021/ja00445a060 833390
Kutney, J. P. et al. Synthetic studies in the Veratrum alkaloid series. The total synthesis of verticine. J. Am. Chem. Soc. 99, 964–966 (1977).833390 10.1021/ja00445a060
20. Giannis A Heretsch P Sarli V Stößel A Synthesis of cyclopamine using a biomimetic and diastereoselective approach Angew. Chem., Int. Ed. 2009 48 7911 7914 10.1002/anie.200902520
Giannis, A., Heretsch, P., Sarli, V. & Stößel, A. Synthesis of cyclopamine using a biomimetic and diastereoselective approach. Angew. Chem., Int. Ed. 48, 7911–7914 (2009).10.1002/anie.200902520
21. Sofiadis M Convergent total synthesis of (–)-cyclopamine J. Am. Chem. Soc. 2023 145 21760 21765 10.1021/jacs.3c09085 37782691
Sofiadis, M. et al. Convergent total synthesis of (–)-cyclopamine. J. Am. Chem. Soc. 145, 21760–21765 (2023).37782691 10.1021/jacs.3c09085
22. Shao H Asymmetric synthesis of cyclopamine, a hedgehog (Hh) signaling pathway inhibitor J. Am. Chem. Soc. 2023 145 25086 25092 10.1021/jacs.3c10362 37948601
Shao, H. et al. Asymmetric synthesis of cyclopamine, a hedgehog (Hh) signaling pathway inhibitor. J. Am. Chem. Soc. 145, 25086–25092 (2023).37948601 10.1021/jacs.3c10362
23. Hou W Divergent and gram-scale syntheses of (–)-veratramine and (–)-cyclopamine Nat. Commun. 2024 15 5332 10.1038/s41467-024-49748-2 38909052
Hou, W. et al. Divergent and gram-scale syntheses of (–)-veratramine and (–)-cyclopamine. Nat. Commun. 15, 5332 (2024).38909052 10.1038/s41467-024-49748-2
24. Cassaidy KJ Rawal VH Enantioselective total synthesis of (+)-heilonine J. Am. Chem. Soc. 2021 143 16394 16400 10.1021/jacs.1c08756 34585920
Cassaidy, K. J. & Rawal, V. H. Enantioselective total synthesis of (+)-heilonine. J. Am. Chem. Soc. 143, 16394–16400 (2021).34585920 10.1021/jacs.1c08756
25. Jin Y Hok S Bacsa J Dai M Convergent and efficient total synthesis of (+)-heilonine enabled by C–H functionalizations J. Am. Chem. Soc. 2024 146 1825 1831 10.1021/jacs.3c13492 38226869
Jin, Y., Hok, S., Bacsa, J. & Dai, M. Convergent and efficient total synthesis of (+)-heilonine enabled by C–H functionalizations. J. Am. Chem. Soc. 146, 1825–1831 (2024).38226869 10.1021/jacs.3c13492
26. Stork G Synthetic study toward total synthesis of (±)−4-methylenegermine Org. Lett. 2017 19 5150 5153 10.1021/acs.orglett.7b02434 28876074
Stork, G. et al. Synthetic study toward total synthesis of (±)−4-methylenegermine. Org. Lett. 19, 5150–5153 (2017).28876074 10.1021/acs.orglett.7b02434
27. Kupchan SM Narayanan CR Veratrum alkaloids. XXVIII. The structure and configuration of germine J. Am. Chem. Soc. 1959 81 1913 1921 10.1021/ja01517a033
Kupchan, S. M. & Narayanan, C. R. Veratrum alkaloids. XXVIII. The structure and configuration of germine. J. Am. Chem. Soc. 81, 1913–1921 (1959).10.1021/ja01517a033
28. Kupchan SM Veratrum alkaloids. XXXVIII. The structure and configuration of protoverine J. Am. Chem. Soc. 1960 82 2242 2251 10.1021/ja01494a038
Kupchan, S. M. et al. Veratrum alkaloids. XXXVIII. The structure and configuration of protoverine. J. Am. Chem. Soc. 82, 2242–2251 (1960).10.1021/ja01494a038
29. Tang J Four new germine esters from Veratrum dahuricum Helv. Chim. Acta 2007 90 769 775 10.1002/hlca.200790078
Tang, J. et al. Four new germine esters from Veratrum dahuricum. Helv. Chim. Acta 90, 769–775 (2007).10.1002/hlca.200790078
30. Tanaka N Suto S Kobayashi J Veramadines A and B, new steroidal alkaloids from veratrum maackii var. japonicum Chem. Pharm. Bull. 2012 59 909 912 10.1248/cpb.59.909
Tanaka, N., Suto, S. & Kobayashi, J. Veramadines A and B, new steroidal alkaloids from veratrum maackii var. japonicum. Chem. Pharm. Bull. 59, 909–912 (2012).10.1248/cpb.59.909
31. Guo Y Enantioselective total synthesis of (–)-zygadenine J. Am. Chem. Soc. 2023 145 20202 20207 10.1021/jacs.3c08039 37683183
Guo, Y. et al. Enantioselective total synthesis of (–)-zygadenine. J. Am. Chem. Soc. 145, 20202–20207 (2023).37683183 10.1021/jacs.3c08039
32. Woodward RB Brutcher FV cis-Hydroxylation of a synthetic steroid intermediate with iodine, silver acetate and wet acetic acid J. Am. Chem. Soc. 1958 80 209 211 10.1021/ja01534a053
Woodward, R. B. & Brutcher, F. V. cis-Hydroxylation of a synthetic steroid intermediate with iodine, silver acetate and wet acetic acid. J. Am. Chem. Soc. 80, 209–211 (1958).10.1021/ja01534a053
33. Cheng C Brookhart M Iridium-catalyzed reduction of secondary amides to secondary amines and imines by diethylsilane J. Am. Chem. Soc. 2012 134 11304 11307 10.1021/ja304547s 22770123
Cheng, C. & Brookhart, M. Iridium-catalyzed reduction of secondary amides to secondary amines and imines by diethylsilane. J. Am. Chem. Soc. 134, 11304–11307 (2012).22770123 10.1021/ja304547s
34. Boger DL McKie JA An efficient synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol−4-one (CBI): an enhanced and simplified analog of the CC-1065 and duocarmycin alkylation subunits J. Org. Chem. 1995 60 1271 1275 10.1021/jo00110a034
Boger, D. L. & McKie, J. A. An efficient synthesis of 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol−4-one (CBI): an enhanced and simplified analog of the CC-1065 and duocarmycin alkylation subunits. J. Org. Chem. 60, 1271–1275 (1995).10.1021/jo00110a034
35. El Sayed KA McChesney JD Halim AF Zaghloul AM Lee I-S A study of alkaloids in Veratrum viride Aiton Pharm. Biol. 1996 34 161 173
El Sayed, K. A., McChesney, J. D., Halim, A. F., Zaghloul, A. M. & Lee, I.-S. A study of alkaloids in Veratrum viride Aiton. Pharm. Biol. 34, 161–173 (1996).
